I just had a particular thought over here...
what if you took the common method of o-demethylating common psychoactive compounds with HBr and then N-acetylating them with acetic anhydride. The advantge of this is produce new compounds that are LEGAL and still retain the parent compounds' psychoactive fx, and possibly make them more potent or atleast about the same. My ideas include:
DXM-->DXO-->"DXA"
ibogaine-->noribogaine-->"aceibogaine"
methylone-->MDHOCAT-->"acelone"(same could be done with MDMA)
obviously this rule applies to traditional opiates but for compounds with other activities i think this would be a great application. Here's my logic...
Shulgin says that for the N-hydroxylated psychedelic/empathogenic phenethylamines are essentially the sameas thier parent compounds, basically the HO on MDA(MDOH) is supposed to be a natural metabolite just as with most opiates and if I remember correctly the potency was closer to that of MDMA and somewhere between MDA and MDMA in FX. Acetylating 4-HO-tryptamines is different I believe because the acetyl is not at the N-position. So naturally this should be able to be done with methylone which is on quazi legal making a much harder to criminalize compound that is just as good.
With DXM the quite clrealy the same logical order as with it opiate other halves. DXO is proven to be more potent than DXM as an NMDA antagonist. So if codiene would be to DXM as Morphine would be to DXO then acetylating it should increase it's affinity even more making heroin is to DXA.
Even if it doesn't increase the potency in any of these it should be atleast on the same potency wise as with the 4-aco-tryptamines are to 4-ho-Ts
what if you took the common method of o-demethylating common psychoactive compounds with HBr and then N-acetylating them with acetic anhydride. The advantge of this is produce new compounds that are LEGAL and still retain the parent compounds' psychoactive fx, and possibly make them more potent or atleast about the same. My ideas include:
DXM-->DXO-->"DXA"
ibogaine-->noribogaine-->"aceibogaine"
methylone-->MDHOCAT-->"acelone"(same could be done with MDMA)
obviously this rule applies to traditional opiates but for compounds with other activities i think this would be a great application. Here's my logic...
Shulgin says that for the N-hydroxylated psychedelic/empathogenic phenethylamines are essentially the sameas thier parent compounds, basically the HO on MDA(MDOH) is supposed to be a natural metabolite just as with most opiates and if I remember correctly the potency was closer to that of MDMA and somewhere between MDA and MDMA in FX. Acetylating 4-HO-tryptamines is different I believe because the acetyl is not at the N-position. So naturally this should be able to be done with methylone which is on quazi legal making a much harder to criminalize compound that is just as good.
With DXM the quite clrealy the same logical order as with it opiate other halves. DXO is proven to be more potent than DXM as an NMDA antagonist. So if codiene would be to DXM as Morphine would be to DXO then acetylating it should increase it's affinity even more making heroin is to DXA.
Even if it doesn't increase the potency in any of these it should be atleast on the same potency wise as with the 4-aco-tryptamines are to 4-ho-Ts

